DCPH — Deciphera Pharmaceuticals Share News
0.000.00%
- $2.21bn
- $1.94bn
- $163.36m
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-3M, Phibro Animal Health, copper miners
U.S. STOCKS ON THE MOVE-Revvity, Southern Co, Duke Energy
Deciphera Pharmaceuticals Inc expected to post a loss of 55 cents a share - Earnings Preview
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Fulton, Deciphera Pharmaceuticals, VivoPower
Brief: Deciphera Pharmaceuticals Says If Deal Terminated Under Certain Conditions, Co To Pay ONO Pharmaceutical A Termination Fee Of $78.8 Mln
Brief: Deciphera Pharmaceuticals To Be Acquired By ONO Pharmaceutical For $2.4 Billion
Japan's Ono Pharmaceutical to buy Deciphera for $2.4 billion (updated)
Japan's ONO Pharmaceutical to buy Deciphera for $2.4 billion
U.S. RESEARCH ROUNDUP-American Express, Cintas, Kimberly-Clark
U.S. RESEARCH ROUNDUP-Dick's Sporting Goods, Nvidia, PVH
Deciphera Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: Deciphera Pharmaceuticals Q4 Basic EPS USD -0.54 Vs. IBES Estimate USD -0.58
Deciphera Pharmaceuticals Inc expected to post a loss of 58 cents a share - Earnings Preview
Brief: Genesis Pharma Announces Distribution Agreement With Deciphera Pharma To Commercialize Ripretinib In 14 EU Markets